Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

BACKGROUND: It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Blue, Thomas R., Gordon, Michael S., Schwartz, Robert P., Couvillion, Kathryn, Vocci, Frank J., Fitzgerald, Terrence T., O’Grady, Kevin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886176/
https://www.ncbi.nlm.nih.gov/pubmed/31787108
http://dx.doi.org/10.1186/s13722-019-0172-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886176/
https://www.ncbi.nlm.nih.gov/pubmed/31787108
http://dx.doi.org/10.1186/s13722-019-0172-2

Ejemplares similares